Treatment of calcium dobesilate tablets capsules combined yimaikang for retinal vein occlusion

VernacularTitle:羟苯磺酸钙胶囊联合益脉康片治疗视网膜静脉阻塞
Author: Hui-Juan, ZHENG
Publication Type:Journal Article
Keywords: retinal vein occlusion; calcium dobesilate capsule; yimaikang tablet; clinical effect
From: International Eye Science 2015;(2):346-348
CountryChina
Language:Chinese
Abstract: AlM: To observe the clinical curative effect of calcium dobesilate capsule and yimaikang tablet for treating retinal vein occlusion ( RVO) .METHODS:A total of 120 patients (167 eyes) with RVO were divided into 2 groups at random. The control group of 60 cases ( 82 eyes ) were given calcium dobesilate capsule, and the treatment group of 60 cases ( 85 eyes ) received calcium dobesilate capsule and yimaikang tablet. Changes of visual acuity and clinical effects after 3 courses of treatment were compared and analyzed for all patients.RESULTS: Markedly effective 15 cases ( 23 eyes ) , effective 42 cases (57 eyes) and invalid 3 cases (5 eyes) in the 60 cases (85 eyes) of the treatment group, the total effective rate was 94. 1%. Eighty-two eyes of 60 cases in the control group, markedly effective in 8 cases ( 12 eyes), effective 38 cases (49 eyes), ineffective 14 cases (21 eyes), The total effective rate was 74. 4% in the control group. There were significant differences between the 2 groups of curative effect, and low incidence rate of adverse reaction. CONCLUSlON: Calcium dobesilate capsules and yimaikang tablet is effective and safe in the treatment of RVO.